Clorox director granted deferred stock units

Clorox director Pierre R. Breber reported routine compensation-related awards of Deferred Stock Units tied 1-for-1 to Clorox common stock.

Rhea-AI Filing Summary

Clorox director Pierre R. Breber reported routine compensation-related awards of Deferred Stock Units tied 1-for-1 to Clorox common stock. On March 31, 2026, he acquired 325.6779 Deferred Stock Units, bringing his holdings to 3100.0674 units. On February 13, 2026, he had received an additional 27.0502 units.

According to the disclosures, some Deferred Stock Units were acquired through dividend reinvestment during the fiscal year under the Independent Directors' Deferred Compensation Plan and some were received in lieu of quarterly director fees. These units will be settled entirely in Clorox stock when Breber retires or otherwise leaves the board, and do not reflect open-market buying or selling.

Insider Trade Summary

Grant/Award: 352.7281 shares

Grant/Award 2 txns

Insider Breber Pierre R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	325.6779	$0.00	$0.00
Grant/Award	Deferred Stock Units	27.0502	$0.00	$0.00

Holdings After Transaction: Deferred Stock Units — 3,100.0674 contracts (Direct)

Footnotes (4)

1. F1. 1-for-1
2. F2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
3. F3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
4. F4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

Key Figures

Deferred Stock Units granted: 325.6779 units Deferred Stock Units granted: 27.0502 units Deferred Stock Units held: 3100.0674 units +1 more

4 metrics

Deferred Stock Units granted 325.6779 units Award on March 31, 2026

Deferred Stock Units granted 27.0502 units Award on February 13, 2026

Deferred Stock Units held 3100.0674 units Total after March 31, 2026 transaction

Unit-to-share ratio 1-for-1 Each Deferred Stock Unit linked to one Clorox share

Key Terms

Deferred Stock Units, Independent Directors' Deferred Compensation Plan, dividend reinvestment, in lieu of receipt of quarterly director's fees

4 terms

Deferred Stock Units financial

"Deferred Stock Units acquired through dividend reinvestment during the fiscal year"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Independent Directors' Deferred Compensation Plan financial

"during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan"

A deferred compensation plan for independent directors lets outside board members postpone receiving part of their fees or stock awards until a later date, often when they retire or leave the board. Think of it as choosing to put pay into a company-run savings plan that grows and pays out later; it matters to investors because it affects director incentives, future cash or share obligations, and how aligned independent directors are with long-term company performance.

dividend reinvestment financial

"Deferred Stock Units acquired through dividend reinvestment during the fiscal year"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

in lieu of receipt of quarterly director's fees financial

"Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Clorox (CLX) director Pierre R. Breber report?

Pierre R. Breber reported two acquisitions of Deferred Stock Units as director compensation. He received 27.0502 units on February 13, 2026 and 325.6779 units on March 31, 2026, increasing his total Deferred Stock Unit holdings to 3100.0674 units.

Are Pierre R. Breber’s Clorox (CLX) Deferred Stock Unit awards open-market purchases?

No, the reported Deferred Stock Units are compensation-related, not open-market purchases. They were acquired through dividend reinvestment and in lieu of quarterly director fees under an independent directors’ deferred compensation plan, and therefore do not represent discretionary buying or selling of Clorox shares.

How many Clorox (CLX) Deferred Stock Units does Pierre R. Breber now hold?

After the March 31, 2026 award, Pierre R. Breber holds 3100.0674 Deferred Stock Units. Each unit is linked 1-for-1 to Clorox common stock and will be settled entirely in shares when he retires or otherwise leaves his position as a director.

How are Clorox (CLX) Deferred Stock Units for directors settled and when?

Clorox Deferred Stock Units for directors are settled 100% in Clorox stock. Settlement occurs upon the director’s retirement or other termination of service from the board, meaning directors defer receipt of actual shares until they leave board service, aligning part of their compensation with long-term company performance.

What plan governs Pierre R. Breber’s dividend reinvestment in Clorox (CLX) Deferred Stock Units?

Dividend reinvestment into Deferred Stock Units occurs under Clorox’s Independent Directors' Deferred Compensation Plan. During the fiscal year, dividends that would have been paid in cash are instead reinvested to acquire additional Deferred Stock Units credited to the director’s account, increasing deferred equity-linked compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Breber Pierre R

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CALIFORNIA 94612-1888

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	02/13/2026		A(2)	V	27.0502		(3)	(3)	Common Stock	27.0502	$0.0000	2,774.3895	D
Deferred Stock Units	(1)	03/31/2026		A(4)		325.6779		(3)	(3)	Common Stock	325.6779	$0.0000	3,100.0674	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)